Published in Immunobiology on July 01, 1998
Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis. Br J Pharmacol (2007) 0.88
Neopterin-induced expression of intercellular adhesion molecule-1 (ICAM-1) in type II-like alveolar epithelial cells. Clin Exp Immunol (1999) 0.85
Neopterin inhibits ATP-induced calcium release in alveolar epithelial cells in vitro. Mediators Inflamm (2002) 0.76
Influence of neopterin and 7,8-dihydroneopterin on the replication of Coxsackie type B5 and influenza A viruses. Med Microbiol Immunol (2006) 0.76
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol (1993) 3.37
Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med (1984) 3.31
Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol Today (1988) 3.13
Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem (1997) 2.39
Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion (1999) 2.32
Neopterin as a marker for immune system activation. Curr Drug Metab (2002) 2.25
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity (1995) 2.19
Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids. Chemotherapy (1972) 2.12
Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol (2000) 2.11
Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem (1993) 1.98
Immune activation and psoriasis. Lancet (1991) 1.93
Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J Exp Med (1990) 1.81
Pharmacokinetics of sulfamethoxazole plus trimethoprim in man and their distribution in the rat. Chemotherapy (1970) 1.77
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol (1995) 1.74
Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS (2001) 1.63
Temporary extracorporeal membrane oxygenation in the treatment of acute traumatic lung injury. Can J Anaesth (1998) 1.63
Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J (1993) 1.61
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer. J Clin Oncol (1998) 1.61
Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem (1989) 1.59
Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr (1999) 1.53
An evaluation of low-cost progression markers in HIV-1 seropositive Zambians. HIV Med (2000) 1.51
vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J Virol (1995) 1.51
Plasma levels and derived pharmacokinetic characteristics of unchanged nitrazepam in man. Arzneimittelforschung (1973) 1.51
In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin. Crit Care Med (2001) 1.49
Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. Transplantation (1983) 1.47
Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton. J Cell Biol (1999) 1.46
Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Br J Cancer (2002) 1.44
The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1. Oncogene (2006) 1.42
Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci (1987) 1.42
Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. J Antimicrob Chemother (2001) 1.42
Reducing HIV transmission by seronegative blood. Lancet (1992) 1.41
Evaluation of the adaptive learning environments model. Except Child (1988) 1.40
Altered iron metabolism and the anemia of chronic disease: a role of immune activation. Blood (1992) 1.39
Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function. Antibiot Chemother (1971) (1974) 1.37
Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem J (1994) 1.36
Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem (1993) 1.35
Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. J Immunol (1983) 1.34
Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques. J Virol (2001) 1.33
Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res (2003) 1.32
Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. Biochem J (1989) 1.31
Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr Med Chem (2003) 1.31
Effects of systematic formative evaluation: a meta-analysis. Except Child (1986) 1.29
Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline. Clin Infect Dis (2001) 1.29
Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J Gen Virol (1996) 1.27
Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol Cell Biol (1994) 1.27
The human immunodeficiency virus type 1 nef gene can to a large extent replace simian immunodeficiency virus nef in vivo. J Virol (1999) 1.26
Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Intensive Care Med (2000) 1.25
Comparative toxicological, chemotherapeutic and pharmacokinetic studies with sulphormethoxine and other sulphonamides in animals and man. Chemotherapy (1969) 1.21
Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2. J Virol (1997) 1.20
Enhanced tryptophan degradation in systemic lupus erythematosus. Immunobiology (2000) 1.20
Characteristics of interferon induced tryptophan metabolism in human cells in vitro. Biochim Biophys Acta (1989) 1.19
Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp Hematol (1992) 1.17
Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis (1993) 1.17
Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem (2010) 1.16
Elevated urinary neopterin levels in patients with the acquired immunodeficiency syndrome (AIDS). A preliminary report. Hoppe Seylers Z Physiol Chem (1983) 1.14
Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Lett (1993) 1.14
Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype. Clin Cancer Res (2001) 1.13
Determination of neopterin in serum and urine. Clin Chem (1987) 1.12
Immune activation and degradation of tryptophan in coronary heart disease. Eur J Clin Invest (2003) 1.12
Linkage of cell-mediated immunity to iron metabolism. Immunol Today (1995) 1.11
Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab (2008) 1.11
Acute respiratory failure associated with catastrophic antiphospholipid syndrome. J Intern Med (2000) 1.10
Protein kinase Ctheta, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur J Immunol (1999) 1.09
Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species. Kidney Int (1997) 1.09
Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection. Biochem Pharmacol (1997) 1.09
Immunization with tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection. Virology (1992) 1.09
Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation. Kidney Int (2006) 1.08
Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe Seyler (1989) 1.08
Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. J Appl Physiol (1985) (2001) 1.08
Decreased plasma tryptophan in pregnancy. Obstet Gynecol (1996) 1.08
Tryptophan degradation and immune activation in Alzheimer's disease. J Neural Transm (Vienna) (2000) 1.08
Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation. J Acquir Immune Defic Syndr (1994) 1.07
Who will get AIDS? Lancet (1986) 1.07
Do students with and without lexical retrieval weaknesses respond differently to instruction? J Learn Disabil (2004) 1.07
CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIV(mac251) infection. Mucosal Immunol (2008) 1.07
Unintentional arterial puncture during cephalic vein cannulation: case report and anatomical study. Br J Anaesth (2004) 1.06
Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med (2001) 1.06
Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res (2009) 1.05
Expression and biochemical characterization of human protein kinase C-theta. Eur J Biochem (1994) 1.04
Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res (1999) 1.04
Simultaneous determination of neopterin and creatinine in serum with solid-phase extraction and on-line elution liquid chromatography. Clin Chem (1987) 1.04
Activation of p56lck by p72syk through physical association and N-terminal tyrosine phosphorylation. Mol Cell Biol (1994) 1.04
Recovery of muscles of old rats after hindlimb immobilisation by external fixation is impaired compared with those of young rats. Exp Gerontol (2001) 1.03
Posttransplant neopterin excretion in renal allograft recipients--a reliable diagnostic aid for acute rejection and a predictive marker of long-term graft survival. Transplantation (1991) 1.03
Tryptophan degradation to control T-cell responsiveness. Immunol Today (2000) 1.03
Incidence of lower thoracic ligamentum flavum midline gaps. Br J Anaesth (2005) 1.02
Neopterin as an index of immune response in patients with tuberculosis. Lung (1984) 1.02
In vivo activation of CD4+ cells in AIDS. Science (1987) 1.02
Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Cancer Res (1990) 1.01